SCHEMBL25959539

SCHEMBL25959539

CC(C)N1CCC12CCOC(CC(C)N1CCC13CCCNC3)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23338573 0.77 SOS1 (0.46) —
SCHEMBL25124976 0.68 SOS1 (0.46) —
SCHEMBL21945578 0.68 SOS1 (0.46) —
SCHEMBL24720256 0.68 SOS1 (0.39) —
SCHEMBL27443832 0.66 SOS1 (0.52) —
SCHEMBL21210664 0.64 SOS1 (0.48) —
SCHEMBL24568091 0.63 SOS1 (0.41) —
SCHEMBL17789639 0.63 SOS1 (0.45) —
SCHEMBL22989400 0.62 SOS1 (0.34) —
SCHEMBL25785225 0.61 SOS1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233569-A1 METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-07-27 — — US disclosed
Send feedback